Analysts

Yeti Holdings

Analysts Goldman Sachs upgraded Yeti Holdings (YETI) to Buy and raised target price to $63 (upside +23%)

Goldman Sachs has upgraded Yeti Holdings to a 'buy' rating, reflecting increased confidence in the company's growth potential in the outdoor recreation market, particularly in drinkware products. This upgrade comes with a new price target of $63, suggesting a 23% upside from recent trading levels.
Eli Lilly

Eli Lilly to Acquire AtaiBeckley for Up to $3.8 Billion, Signaling Big Pharma’s Shift Towards Psychedelic Drugs for Mental Health Treatment

Eli Lilly's acquisition of AtaiBeckley for up to $3.8 billion highlights the pharmaceutical industry's growing interest in psychedelic drugs as viable treatments for mental health disorders, particularly treatment-resistant depression. This move signals a potential shift in the market, as positive clinical trial results and regulatory support pave the way for broader acceptance and commercialization of these therapies.
PayPal Oracle Cintas IBM Super Micro Computer

Analysts recommend buying Oracle (ORCL) despite recent overselling amid AI spending concerns

This week, artificial intelligence-related stocks faced significant declines, primarily due to concerns over chipmakers and disappointing earnings reports, leading to a broader market downturn. However, some stocks are now considered oversold and may present buying opportunities for investors.
Ulta Beauty Target

Analysts Morgan Stanley forecast K-beauty sales in the U.S. to reach $4 billion by 2026, driven by rising consumer demand

The rapid rise of Korean beauty products in the U.S. market, exemplified by Olive Young's successful store openings, indicates a significant shift in consumer preferences towards K-beauty, which could reshape the beauty retail landscape and impact major players in the sector.